Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections (2018)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1038/s41374-017-0007-2
- Subjects: DELEÇÃO DE GENES; HIBRIDIZAÇÃO; GENES SUPRESSORES DE TUMOR; NEOPLASIAS; GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Laboratory Investigation
- ISSN: 0023-6837
- Volume/Número/Paginação/Ano: v. 98, n. 4, p. 403-413, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: publisher-specific-oa
-
ABNT
YOSHIMOTO, Maisa et al. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Laboratory Investigation, v. 98, n. 4, p. 403-413, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41374-017-0007-2. Acesso em: 24 abr. 2024. -
APA
Yoshimoto, M., Ludkovski, O., Good, J., Pereira, C., Gooding, R. J., McGowan-Jordan, J., et al. (2018). Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Laboratory Investigation, 98( 4), 403-413. doi:10.1038/s41374-017-0007-2 -
NLM
Yoshimoto M, Ludkovski O, Good J, Pereira C, Gooding RJ, McGowan-Jordan J, Boag A, Evans A, Tsao M-S, Nuin P, Squire JA. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections [Internet]. Laboratory Investigation. 2018 ; 98( 4): 403-413.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1038/s41374-017-0007-2 -
Vancouver
Yoshimoto M, Ludkovski O, Good J, Pereira C, Gooding RJ, McGowan-Jordan J, Boag A, Evans A, Tsao M-S, Nuin P, Squire JA. Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections [Internet]. Laboratory Investigation. 2018 ; 98( 4): 403-413.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1038/s41374-017-0007-2 - Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- Clinical implications of PTEN loss in prostate cancer
- A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Informações sobre o DOI: 10.1038/s41374-017-0007-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
